HOMEABOUT USPRODUCTSNEWSCONTACT US
GLC BIOTECHNOLOGY, INC.
A molecular cancer dignostics company
Team

GLC's Competitive Advantages
Fecal DNA testing is highly complex, presenting a significant challenge to implementation in
clinical labs. GLC's proprietary technologies and DNA markers make fecal DNA testing much
simpler, easier to implement, and more cost-effective. Preliminary clinical studies indicate
that GLC's test will have excellent sensitivity and specificity with much improved operational
characteristics. 
Intellectual Property